The 2022 ACR vaccination guideline: a call-to-action.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 36973498.
- Also identified by DOI 10.1038/s41584-023-00954-0 and PMC identifier 10042393.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Among the limited quality and quantity of evidence on vaccination use in individuals with rheumatic and musculoskeletal diseases, a new guideline, developed with a rigorous methodology, provides useful support to clinicians and patients in making health-related decisions. Most recommendations are conditional, serving as a call to action for further research.